Cencora Q4 FY24: where the revenue came from and where it went
The whole income statement of Cencora for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2024
- Reported
- Nov 26, 2024
Revenue$79.05B
+15% year over year
Gross profit$2.49B
3% margin
Operating profit$0.13B
0% margin
Net profit$<0.01B
0% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 79.05 | 100% | +15% |
| US healthcare solutions | 71.67 | 91% | +16% |
| International healthcare | 7.38 | 9% | +6% |
| Cost of revenue | −76.56 | 97% | |
| Gross profit | 2.49 | 3% margin | +0pp |
| SG&A | −1.49 | 2% | +0pp |
| Other | −0.88 | 1% | +0pp |
| Operating profit | 0.13 | 0% margin | −1pp |
| Tax | −0.12 | ||
| Net profit | <0.01 | 0% margin | −1pp |
112 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest